U0126
U0126 has been studied in 2 papers since 2016: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Jul 29, 2021: “Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats”.
1 new paper in 30 daysSee all 15 papers on U0126
At a glance
The findings reach mice, none yet in people. 4 independent labs in 4 countries.
1 of its findings points the other way.
- 4 independent labs in 4 countries
- 1 finding against
- Funders: Institute for Intelligent Healthcare, Tsinghua University and others
- Animals2
What did studies of U0126 find?
4Studies of U0126 measured 4 outcomes, among them muscle regeneration, NOX4 and neuropathic pain.
Muscle regeneration
upin mice1downin zebrafish1
2 studies
Muscle regeneration
upin mice1downin zebrafish1
U0126 improves muscle regeneration in mice after injury.
“ERK inhibition by U0126 not only induced recovery of myotube formation in old myoblasts but also facilitated muscle regeneration after injury in aged muscle.”
Animalsafter injuryskeletal muscle
Aging
U0126 impairs muscle regeneration in injured extraocular muscle.
“inhibition of MEK activity with U0126 mimicked the phenotype of the Fgf receptor inhibition on both muscle regeneration and cell proliferation”
Animalsin injured extraocular muscleextraocular muscle
Fgf regulates dedifferentiation during skeletal muscle regeneration in adult zebrafish
Cellular signalling
NOX4
downin rat cells1
1 study
NOX4
downin rat cells1
U0126 decreases NOX4 in palmitic acid-treated DRG neurons.
“while U0126 partially attenuated the PA-induced upregulation of NOX4 and other pathological changes.”
Cellsin palmitic acid-treated DRG neurons
Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats
Aging
Neuropathic pain
downin rats1
1 study
Neuropathic pain
downin rats1
U0126 decreases neuropathic pain in obese CCD rats.
“Administration of U0126 could partially elevate the PWMT and reduce the protein expression of NOX4 and the above pathological changes in obese CCD rats.”
Animalsin obese CCD rats
Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats
Aging
P16 expression
downin mouse cells1
1 study
P16 expression
downin mouse cells1
U0126 decreases P16 expression in lower-dose Ang II and Aβ combination treatment.
“These changes by lower dose combination, except in p-IκB expression and NF-κB activity, were significantly inhibited by pretreatment with U0126 (ERK inhibitor)”
Cellsin lower-dose Ang II and Aβ combination treatmentbrain vascular smooth muscle cell4 daysmales
Angiotensin II and Amyloid-β Synergistically Induce Brain Vascular Smooth Muscle Cell Senescence
American journal of hypertension